ICD-10 Code L86: Keratoderma in diseases classified elsewhere

Key Takeaways

ICD-10 Code L86 (Keratoderma in diseases classified elsewhere) is a billable ICD-10-CM code valid for 2026 fiscal year claims

L86 is a manifestation code: the underlying etiology (e.g. Reiter’s disease, hypothyroidism, or an associated malignancy) must be sequenced first on every claim

Skipping the Code First instruction is the most common denial trigger; payers reject claims where L86 appears without a paired etiology code

Pabau’s claims management software helps dermatology practices enforce correct code sequencing and reduce L86-related claim errors

ICD-10 Code L86 is a billable ICD-10-CM code for keratoderma in diseases classified elsewhere – abnormal skin thickening that occurs as a manifestation of an underlying systemic disease. It is a manifestation code, so the underlying etiology must be sequenced first on every claim; omitting it is the most common reason L86 claims are denied. This guide covers the L86 definition, the etiology-manifestation coding convention, related and differential codes, documentation requirements, and practical billing guidance for dermatology and aesthetics practices.

ICD-10 Code L86: Definition and clinical description

ICD-10 Code L86 describes keratoderma in diseases classified elsewhere. It falls under ICD-10-CM Chapter 12 (Diseases of the skin and subcutaneous tissue), within the L80-L99 sub-range covering other disorders of the skin and subcutaneous tissue, as confirmed by the CDC/NCHS ICD-10-CM web tool.

Keratoderma refers to abnormal thickening of the skin, most commonly affecting the palms and soles (palmoplantar distribution). When it arises as a consequence of a systemic disease rather than as a primary dermatological condition, L86 is the appropriate code. The skin change is the manifestation; the underlying disease is the root cause.

The ICD-10-CM Tabular List gives a Code First example of Reiter’s disease (reactive arthritis, M02.3-). Other systemic causes of acquired keratoderma include hypothyroidism and lymphoma or other malignancies; diabetes mellitus is sometimes cited but is a less established association. The code is valid for the 2026 ICD-10-CM fiscal year with no changes noted in the current update cycle.

L86 carries no inclusion terms of its own; its only Tabular List notes are the Code First instruction and an Excludes1 list (gonococcal keratoderma, and keratoderma due to vitamin A deficiency, E50.8). Primary inherited blistering disorders such as epidermolysis bullosa are coded in Chapter 17 (Q81.-), not here, even when they involve palmoplantar thickening. Practices using dermatology EMR software can configure L86 pairings to flag etiology requirements at documentation time, reducing sequencing errors before claims go out.

Etiology-manifestation convention: how to sequence ICD-10 Code L86 correctly

The etiology-manifestation convention is the most clinically significant coding rule attached to L86. It applies whenever a condition has both an underlying cause and a body-system manifestation of that cause.

The rule, as defined by the CMS ICD-10 coding guidelines, requires the underlying etiology code to be sequenced first, with the manifestation code (L86) listed second. This is not optional. The ICD-10-CM Tabular List contains a “Code First” instruction at L86, which coders must follow for compliant claim submission.

Understanding the distinction between etiology-manifestation coding conventions across code families helps coders avoid applying the Code First rule inconsistently between chapters. The pattern is the same whether the manifestation is neurological, ophthalmological, or dermatological: underlying disease comes first, manifestation second.

Correct sequencing examples for L86

• Keratoderma in Reiter’s disease (reactive arthritis): M02.3- (the Tabular List’s named Code First example) + L86
• Keratoderma due to hypothyroidism: E03.9 (Hypothyroidism, unspecified) + L86
• Keratoderma associated with lymphoma: relevant lymphoma code (e.g., C85.90) + L86
• Keratoderma in documented diabetes mellitus: E11.69 (Type 2 diabetes mellitus with other specified complication) + L86, where the provider explicitly links the two

When the etiology is not documented or is uncertain, coders should query the provider rather than sequencing L86 alone. Submitting L86 as the only code on a claim is the most common trigger for denial on these encounters.

Differential and related codes

Accurate coding requires distinguishing L86 from adjacent codes that describe similar-appearing skin changes. The key differentiator is always the clinical context: is this skin thickening a manifestation of a systemic disease, or is it an independent condition?

The most clinically tricky distinction is between L85.1 (acquired keratosis palmaris et plantaris) and L86. Both produce palmoplantar thickening, but L85.1 is appropriate when no systemic disease etiology is documented. If the provider notes “keratoderma in the context of diabetes” or similar, L86 applies with the Code First pairing. If the documentation says nothing about an underlying systemic cause, L85.1 or L85.8 may be the better fit. Accurate skin clinic software that surfaces documentation gaps at encounter close can prevent this ambiguity from reaching billing.

Documentation requirements

Documentation for L86 must support three distinct components: the skin finding, the underlying disease, and the clinical link between them. Any one of these missing from the note makes compliant coding difficult and increases audit exposure.

Payer reviewers look for explicit language connecting the keratoderma to a systemic cause. “Palmoplantar thickening” in isolation does not support L86 unless the note also establishes the etiology. Providers who use claims management software with built-in coding checks can catch this gap before submission rather than after denial. For related guidance on how secondary diagnosis codes interact with primary conditions in other specialties, the sequencing logic follows the same Code First principle.

Required documentation elements

• Skin finding: explicit description of keratoderma (thickened skin, palmoplantar distribution, hyperkeratosis)
• Etiology statement: named systemic condition (e.g., diabetes mellitus type 2, hypothyroidism, lymphoma)
• Causal link: clinical language linking the skin finding to the systemic disease (e.g., “keratoderma secondary to,” “in the context of,” “as a manifestation of”)
• Etiology code documentation: the underlying condition must itself be fully documented and supportable by its own ICD-10 code
• Chronicity and severity: whether the keratoderma is acute, chronic, or recurrent; extent of involvement (focal vs. diffuse)

For encounters involving malignancy as the etiology, document whether the lymphoma or other cancer is active or in remission. The active vs. historical distinction affects which malignancy code is selected and, in turn, the sequencing of L86.

Reduce claim denials with smarter dermatology billing workflows

Pabau helps dermatology and skin practices capture the right documentation at the point of care, enforce code sequencing rules, and submit cleaner claims. See how it works for your practice.

Book a demo

Billing guidance for L86 claims

L86 is a valid billable code, but billing it in isolation will result in a denial on most payer edits. Every claim that includes L86 must also include the etiology code as the primary diagnosis. This is not a payer quirk; it reflects the Code First instruction in the ICD-10-CM Tabular List, which the AAPC Codify ICD-10-CM reference confirms is a mandatory coding convention.

Reimbursement for keratoderma-related encounters varies significantly by payer. Treatment of keratoderma secondary to a systemic condition may be covered under the systemic disease management benefit rather than a standalone dermatology benefit, depending on how the claim is structured. Coverage for any specific keratoderma treatment should be verified with the individual payer before the encounter, as policies differ across commercial plans and Medicare.

Common billing errors with L86

• L86 as sole diagnosis code: submitting without a paired etiology code is the most frequent denial trigger
• Reversed sequencing: listing L86 first and the etiology second violates the Code First instruction
• Using L85.1 instead of L86: when systemic disease is documented, L85.1 is clinically incorrect
• Using L86 when etiology is unconfirmed: if the provider hasn’t established a causal link, query before coding
• Incomplete etiology code: selecting a non-specific etiology code (e.g., E11 without a complication subcode) when a more specific code is available

Patient record management tools that flag incomplete diagnostic pairings at the time of chart closure catch most of these errors before they reach the billing queue. Using patient record management software with structured clinical data fields makes the etiology-manifestation pairing visible to both the provider and the coder in a single workflow, without relying on free-text parsing to identify the link. Good skin condition documentation practices built into the consultation workflow are one of the most effective ways to reduce downstream billing errors on codes like L86.

Related codes and crosswalk context

Understanding where L86 sits within the broader code landscape helps coders build accurate encounter records for complex patients. Dermatology patients with systemic disease often present with multiple skin findings, and accurate coding requires selecting the right code for each distinct clinical finding.

The ICD List reference places L86 adjacent to the L87 range (transepidermal elimination disorders) and within the same L80-L99 sub-range that includes acanthosis nigricans (L83), corns and callosities (L84), and the L85 epidermal thickening group. Knowing how other manifestation codes in ICD-10-CM behave helps build consistent coding habits across specialties.

Common etiology codes paired with L86

• M02.3- – Reiter’s disease (reactive arthritis), the Code First example named in the Tabular List
• E03.9 – Hypothyroidism, unspecified (when thyroid disease is the documented etiology)
• E00-E07 range – Other thyroid disorders when a more specific thyroid code applies
• C81-C96 range – Malignant neoplasms of lymphoid, hematopoietic and related tissue (lymphoma-related keratoderma)
• E11.69 / E10.69 – Type 2 / type 1 diabetes mellitus with other specified complication, when the provider explicitly documents diabetes as the cause

When multiple systemic conditions coexist and either could plausibly explain the keratoderma, the provider should specify in the note which condition is clinically responsible for the skin finding. Coders should not make this determination independently. Querying the provider and documenting the response is the compliant approach, and it protects the practice in the event of a payer audit. The WHO ICD-10 browser provides the international classification context for L86 and adjacent skin codes, which is useful when reviewing claims involving internationally trained clinicians or cross-border documentation.

Practices that use dermatology coding workflows with structured templates for systemic-disease-related skin conditions consistently produce cleaner code pairings than those relying on unstructured notes. Structured digital intake forms that prompt for underlying conditions at registration capture the etiology information before the consultation even begins, giving the provider the clinical context they need to document the causal link accurately. The clinical documentation practices that reduce errors in one specialty apply equally to dermatology coding.

Conclusion

Keratoderma claims fail not because the code is wrong, but because the sequencing is. L86 is a clean, billable code when used correctly: etiology first, manifestation second, and clinical documentation that explicitly names the link between them.

Pabau’s compliance management tools help dermatology and skin practices build the documentation discipline that makes L86 billing straightforward: structured encounter templates, built-in code pairing checks, and claim submission workflows that flag sequencing errors before they reach the payer. To see how Pabau handles dermatology billing compliance end to end, book a demo.

Continue your research

Need dermatology-specific EMR guidance? Dermatology EMR software covers how Pabau supports skin clinic workflows from consultation to claim.

Looking for skin clinic management tools? Skin clinic software explains how to streamline patient records, consent, and billing in one platform.

Want to improve clinical note accuracy? Safer clinical notes provides practical guidance on documentation standards that reduce audit risk.

Frequently Asked Questions